Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPIA | P62937 | 20/20 | 0.75 |
| ▸ | PPIB | P23284 | 17/20 | 0.75 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19861269 | 0.99 | PPIA (0.76) | PPIAPPIBSLCO1B1 | |
| SCHEMBL20076056 | 0.98 | PPIA (0.76) | PPIAPPIBSLCO1B1 | |
| SCHEMBL15182980 | 0.97 | PPIA (0.78) | PPIAPPIBSLCO1B1 | |
| SCHEMBL15182984 | 0.96 | PPIA (0.79) | PPIAPPIBSLCO1B1 | |
| SCHEMBL19861169 | 0.96 | PPIA (0.78) | PPIAPPIBSLCO1B1 | |
| SCHEMBL19861322 | 0.95 | PPIA (0.74) | PPIAPPIBSLCO1B1 | |
| SCHEMBL15182954 | 0.94 | PPIA (0.79) | PPIAPPIBSLCO1B1 | |
| SCHEMBL15182957 | 0.94 | PPIA (0.80) | PPIAPPIBSLCO1B1 | |
| SCHEMBL17523723 | 0.92 | PPIA (0.80) | PPIAPPIBSLCO1B1 | |
| SCHEMBL15182974 | 0.92 | PPIA (0.82) | PPIAPPIBSLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10647747-B2 | Cyclosporin derivatives and uses thereof | S&T GLOBAL INC. (US) | 2020-05-12 | — | — | US | disclosed |
| US-20180105558-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | S&T GLOBAL INC. | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647747-B2 | Cyclosporin derivatives and uses thereof | FKBP5, FKBP1B, MALT1 | PPIA 403/4885PPIB 35/4885SLCO1B1 438/4885 |
| US-20180105558-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | FKBP1B, MALT1, FKBP5 | PPIA 435/4885PPIB 39/4885SLCO1B1 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.